Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Return on Capital Employed (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Return on Capital Employed for 4 consecutive years, with 1.42% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 37.0% to 1.42% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.42%, a 37.0% decrease, with the full-year FY2024 number at 0.93%, down 31.0% from a year prior.
  • Return on Capital Employed was 1.42% for Q3 2025 at Orchestra BioMed Holdings, up from 2.1% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.29% in Q1 2023 to a low of 2.1% in Q2 2025.
  • A 4-year average of 0.88% and a median of 0.81% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: fell -18bps in 2023, then crashed -118bps in 2025.
  • Orchestra BioMed Holdings' Return on Capital Employed stood at 0.37% in 2022, then tumbled by -48bps to 0.54% in 2023, then crashed by -98bps to 1.08% in 2024, then plummeted by -31bps to 1.42% in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Return on Capital Employed are 1.42% (Q3 2025), 2.1% (Q2 2025), and 1.32% (Q1 2025).